The Johns Hopkins University School of Medicine and The Institute for Johns Hopkins Nursing
an Educational Grant
Vertex Pharmaceuticals, Incorporated
The development of new therapies involves new conceptual approaches; these therapies await proof of concept before being accepted as useful means to arrest the progression of the disease. Those “new conceptual approaches” have now advanced, and are on the verge of becoming new therapeutic options. Through these enduring materials, CF clinicians will be better able to
integrate information about these emerging therapies into fundamental therapies in current clinical practice strategies for managing patient expectations.
The Johns Hopkins eSeminar Series provides the educational experience of Hopkins-sponsored lectures, symposia, and seminars for clinicians who cannot attend the live meetings by making these programs available as electronically-delivered enduring materials.
These accredited programs are presented without charge or prerequisite.